Showing results (431-440 of 472) with videos related to

Sort By:
Pageof 48
The Lancet. Oncology|December 3, 2020
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trialJin Won Youn, Soo-Young Hur, Jung Won Woo, et al.
Plos One|September 30, 2011
Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietinSe Jin Im, Sang In Yang, Se Hwan Yang, et al.
International Journal of Antimicrobial Agents|July 18, 2006
Efficacy and safety of gatifloxacin for urinary tract infection in nonspecialized Korean urologic practiceSang Don Lee, Seung Ju Lee, Tae Kon Hwang, et al.
The Lancet. Microbe|February 14, 2022
Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adultsJin Young Ahn, Jeongsoo Lee, You Suk Suh, et al.
Experimental Neurobiology|March 21, 2015
COMP-Ang1 Potentiates EPC Treatment of Ischemic Brain Injury by Enhancing Angiogenesis Through Activating AKT-mTOR Pathway and Promoting Vascular Migration Through Activating Tie2-FAK PathwayHyo Eun Moon, Kyunghee Byun, Hyung Woo Park, et al.
Journal of Atherosclerosis and Thrombosis|August 30, 2021
Phenotypic and Genetic Analyses of Korean Patients with Familial Hypercholesterolemia: Results from the KFH Registry 2020Hyoeun Kim, Chan Joo Lee, Sang-Hyun Kim, et al.
Cancer Research and Treatment|April 2, 2016
Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter StudySung Gu Kang, Eu Chang Hwang, Seung Il Jung, et al.
Korean Circulation Journal|July 3, 2024
Comparison of Statin With Ezetimibe Combination Therapy Versus Statin Monotherapy for Primary Prevention in Middle-Aged AdultsJung-Joon Cha, Soon Jun Hong, Subin Lim, et al.
Clinical Therapeutics|August 6, 2014
Efficacy and safety of 30-mg fimasartan for the treatment of patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, phase III clinical studyJong-Chan Youn, Sang-Hyun Ihm, Jang-Ho Bae, et al.
American Journal of Hypertension|May 18, 2019
Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central StudyEun Joo Cho, Hae Young Lee, Ki Chul Sung, et al.
Pageof 48